Mark van der Garde

585 total citations
20 papers, 354 citations indexed

About

Mark van der Garde is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Mark van der Garde has authored 20 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 8 papers in Immunology and 5 papers in Genetics. Recurrent topics in Mark van der Garde's work include Hematopoietic Stem Cell Transplantation (15 papers), Immune Cell Function and Interaction (6 papers) and Acute Myeloid Leukemia Research (4 papers). Mark van der Garde is often cited by papers focused on Hematopoietic Stem Cell Transplantation (15 papers), Immune Cell Function and Interaction (6 papers) and Acute Myeloid Leukemia Research (4 papers). Mark van der Garde collaborates with scholars based in United Kingdom, Germany and Sweden. Mark van der Garde's co-authors include Suzanne M. Watt, Francesca Gullo, Jaap Jan Zwaginga, Cheen P. Khoo, Rosalba Camicia, Daniel Markeson, Francesco Pappalardo, Santo Motta, Marzio Pennisi and Giulia Russo and has published in prestigious journals such as Nature Communications, Blood and Bioinformatics.

In The Last Decade

Mark van der Garde

18 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark van der Garde United Kingdom 10 173 157 99 63 43 20 354
Federica Serrani Italy 9 266 1.5× 159 1.0× 142 1.4× 62 1.0× 35 0.8× 12 452
Kilian Kelly Australia 10 271 1.6× 218 1.4× 167 1.7× 48 0.8× 46 1.1× 16 477
Rohini Radia United Kingdom 6 152 0.9× 131 0.8× 88 0.9× 53 0.8× 19 0.4× 8 283
Hatixhe Latifi-Pupovci Kosovo 7 188 1.1× 81 0.5× 108 1.1× 37 0.6× 44 1.0× 15 338
Dimitra Zacharaki Sweden 8 232 1.3× 99 0.6× 55 0.6× 104 1.7× 20 0.5× 13 338
Guadalupe R. Fajardo-Orduña Mexico 9 194 1.1× 132 0.8× 70 0.7× 54 0.9× 23 0.5× 16 333
Patrícia Viana Bonini Palma Brazil 10 222 1.3× 106 0.7× 123 1.2× 29 0.5× 26 0.6× 13 387
Ziguang Yan China 9 80 0.5× 115 0.7× 96 1.0× 51 0.8× 38 0.9× 37 353
Veronika S. Urbán Hungary 9 200 1.2× 156 1.0× 169 1.7× 28 0.4× 24 0.6× 12 428

Countries citing papers authored by Mark van der Garde

Since Specialization
Citations

This map shows the geographic impact of Mark van der Garde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark van der Garde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark van der Garde more than expected).

Fields of papers citing papers by Mark van der Garde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark van der Garde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark van der Garde. The network helps show where Mark van der Garde may publish in the future.

Co-authorship network of co-authors of Mark van der Garde

This figure shows the co-authorship network connecting the top 25 collaborators of Mark van der Garde. A scholar is included among the top collaborators of Mark van der Garde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark van der Garde. Mark van der Garde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Garde, Mark van der, Terumasa Umemoto, Valgarður Sigurðsson, et al.. (2024). Lipoprotein metabolism mediates hematopoietic stem cell responses under acute anemic conditions. Nature Communications. 15(1). 8131–8131.
3.
Hecker, Judith S., et al.. (2023). Choosing the source of healthy controls for studies on myeloid malignancies: all bone marrow cells are created equal, but some are more equal than others. Stem Cell Research & Therapy. 14(1). 36–36. 1 indexed citations
4.
Rydström, Anna, Tan Hooi Min Grahn, Abhishek Niroula, et al.. (2023). Functional and molecular profiling of hematopoietic stem cells during regeneration. Experimental Hematology. 127. 40–51. 1 indexed citations
5.
6.
Diesch, Jeannine, Matthias Muhar, Mark van der Garde, et al.. (2021). Inhibition of CBP synergizes with the RNA-dependent mechanisms of Azacitidine by limiting protein synthesis. Nature Communications. 12(1). 6060–6060. 16 indexed citations
7.
Sigurðsson, Valgarður, Yoichi Haga, Hajime Takei, et al.. (2020). Induction of blood-circulating bile acids supports recovery from myelosuppressive chemotherapy. Blood Advances. 4(9). 1833–1843. 11 indexed citations
8.
Peng, Hua, Barbara Kronsteiner, Mark van der Garde, et al.. (2019). Single-cell assessment of transcriptome alterations induced by Scriptaid in early differentiated human haematopoietic progenitors during ex vivo expansion. Scientific Reports. 9(1). 5300–5300. 9 indexed citations
9.
Radulović, Višnja, Mark van der Garde, Shuhei Koide, et al.. (2019). Junctional Adhesion Molecule 2 Represents a Subset of Hematopoietic Stem Cells with Enhanced Potential for T Lymphopoiesis. Cell Reports. 27(10). 2826–2836.e5. 10 indexed citations
10.
Sigurðsson, Valgarður, Shuhei Koide, Višnja Radulović, et al.. (2019). CD244 Marks Non-Functional Hematopoietic Stem Cells with a Mast Cell Signature after Induction of Endoplasmic Reticulum Stress. Blood. 134(Supplement_1). 2474–2474. 1 indexed citations
11.
Hernandez, Diana, Barbara Kronsteiner, Philip Pratt, et al.. (2016). A Novel High-Throughput Screening Platform Reveals an Optimized Cytokine Formulation for Human Hematopoietic Progenitor Cell Expansion. Stem Cells and Development. 25(22). 1709–1720. 10 indexed citations
12.
Radulović, Višnja, Mark van der Garde, Valgarður Sigurðsson, et al.. (2016). Junctional Adhesion Molecule 2 Represents a Novel Subset of Hematopoietic Stem Cells Poised for T Lymphopoiesis. Blood. 128(22). 3862–3862. 1 indexed citations
13.
14.
Garde, Mark van der, Melissa van Pel, Manon C. Slot, et al.. (2015). Direct Comparison of Wharton's Jelly and Bone Marrow-Derived Mesenchymal Stromal Cells to Enhance Engraftment of Cord Blood CD34 + Transplants. Stem Cells and Development. 24(22). 2649–2659. 22 indexed citations
15.
Gullo, Francesca, Mark van der Garde, Giulia Russo, et al.. (2015). Computational modeling of the expansion of human cord blood CD133+ hematopoietic stem/progenitor cells with different cytokine combinations. Bioinformatics. 31(15). 2514–2522. 29 indexed citations
16.
Hensbergen, Yvette van, Mark van der Garde, Anneke Brand, et al.. (2015). Cryopreservation of cord blood CD34+ cells before or after thrombopoietin expansion differentially affects early platelet recovery in NOD SCID mice. Transfusion. 55(7). 1772–1781. 3 indexed citations
17.
Hale, Sarah, Ashley Hale, Youyi Zhang, et al.. (2015). CXCR2 modulates bone marrow vascular repair and haematopoietic recovery post‐transplant. British Journal of Haematology. 169(4). 552–564. 9 indexed citations
18.
Garde, Mark van der, Yvette van Hensbergen, Anneke Brand, et al.. (2014). Thrombopoietin Treatment of One Graft in a Double Cord Blood Transplant Provides Early Platelet Recovery While Contributing to Long-Term Engraftment in NSG Mice. Stem Cells and Development. 24(1). 67–76. 9 indexed citations
19.
Watt, Suzanne M., Francesca Gullo, Mark van der Garde, et al.. (2013). The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential. British Medical Bulletin. 108(1). 25–53. 210 indexed citations
20.
Garde, Mark van der, Björn Winkens, & Frans J.M.E. Roumen. (2012). Increased elective caesarean section rate is not associated with a decreased serious morbidity rate for twins ≥ 32 weeks’ gestation. Journal of Obstetrics and Gynaecology. 32(5). 453–457. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Federica Serrani Breakdown of academic impact, for papers by Kilian Kelly Breakdown of academic impact, for papers by Rohini Radia Breakdown of academic impact, for papers by Hatixhe Latifi-Pupovci Breakdown of academic impact, for papers by Dimitra Zacharaki Breakdown of academic impact, for papers by Guadalupe R. Fajardo-Orduña Breakdown of academic impact, for papers by Patrícia Viana Bonini Palma Breakdown of academic impact, for papers by Ziguang Yan Breakdown of academic impact, for papers by Veronika S. Urbán
Rankless by CCL
2026